Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy

Summary

Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-management support. Participants will be randomized to the iPREP-RRT intervention versus enhanced usual care.

Conditions

• Chronic Kidney Disease
• Hypertension

Interventions

BEHAVIORAL

In-Person Patient Education

In-person patient education about CKD, CKD risk factor management and renal replacement therapy options.

BEHAVIORAL

Commitment to Change

Motivational interviewing to assist participants in committing to change in CKD management or RRT selection.

BEHAVIORAL

Blood pressure monitoring

Participants will learn how to check their blood pressure and will receive a blood pressure cuff for home.

BEHAVIORAL

Written Patient Education

Written patient education booklet about general health care management including taking medications, having a primary care doctor, weight management and exercise.

BEHAVIORAL

Text-based reinforcement for CKD self-management

Patient educator will use text messages based on social cognitive theory to remind participants about and reinforce goals set around CKD self-management, blood pressure control and RRT selection

BEHAVIORAL

Community-based education session, reinforcement for self-management

Patient educator will use provide a "booster" session based on social cognitive theory to remind participants about and reinforce goals set around CKD self-management, blood pressure control and RRT selection

BEHAVIORAL

Text-based reinforcement for general health self-management

Patient educator will use text messages to send general health management messages

Sponsors & Collaborators

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

  collaborator NIH

• University of Chicago

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-09-04

Primary Completion

2026-04-30

Completion

2026-06-30

Countries

• United States

Study Locations